LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial Infection

Cell Host and Microbe

Volumn 24, Issue 2, 2018, Pages 249-260.e4

  Seo, Goo Young ^a,b   Shui, Jr Wen ^a,e   Takahashi, Daisuke ^a,f   Song, Christina ^c   Wang, Qingyang ^a   Kim, Kenneth ^a   Mikulski, Zbigniew ^a   Chandra, Shilpi ^a   Giles, Daniel A ^a   Zahner, Sonja ^a   Kim, Pyeung Hyeun ^b   Cheroutre, Hilde ^a   Colonna, Marco ^c   Kronenberg, Mitchell ^a,d  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b Kangwon National University   (South Korea)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^f KEIO UNIVERSITY   (Japan)

Author keywords

CCR6; HVEM; IFN ; ileum; infection; innate lymphoid cells; LIGHT; Yersinia enterocolitica

Indexed keywords

GAMMA INTERFERON; HERPESVIRUS ENTRY MEDIATOR; LIGHT PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CCR6 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR6; CYTOKINE; HERPESVIRUS ENTRY MEDIATOR LIGAND; HOMEODOMAIN PROTEIN; NEUROPEPTIDE; RAG-1 PROTEIN; TNFSF14 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; CYTOKINE RELEASE; FOOD POISONING; HOST RESISTANCE; LYMPHOID CELL; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMALL INTESTINE; YERSINIOSIS; ADULT; ANIMAL; C57BL MOUSE; DISEASE MODEL; ENTEROBACTERIACEAE INFECTION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE; MALE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; PROTEIN TRANSPORT; SPLEEN; YERSINIA ENTEROCOLITICA;

ADOPTIVE TRANSFER; ADULT; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE INFECTIONS; HOMEODOMAIN PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-GAMMA; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDES; PROTEIN TRANSPORT; RECEPTORS, CCR6; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; SIGNAL TRANSDUCTION; SPLEEN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; YERSINIA ENTEROCOLITICA;

EID: 85050632181     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2018.07.008     Document Type: Article

References (58)

1. Ahn, Y.O., Weeres, M.A., Neulen, M.L., Choi, J., Kang, S.H., Heo, D.S., Bergerson, R., Blazar, B.R., Miller, J.S., Verneris, M.R., Human group 3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation. Eur. J. Immunol. 45 (2015), 2335–2342.
2. Artis, D., Spits, H., The biology of innate lymphoid cells. Nature 517 (2015), 293–301.
3. Autenrieth, I.B., Kempf, V., Sprinz, T., Preger, S., Schnell, A., Defense mechanisms in Peyer's patches and mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines. Infect. Immun. 64 (1996), 1357–1368.
4. Barthel, M., Hapfelmeier, S., Quintanilla-Martinez, L., Kremer, M., Rohde, M., Hogardt, M., Pfeffer, K., Russmann, H., Hardt, W.D., Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71 (2003), 2839–2858.
5. Bjorklund, A.K., Forkel, M., Picelli, S., Konya, V., Theorell, J., Friberg, D., Sandberg, R., Mjosberg, J., The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing. Nat. Immunol. 17 (2016), 451–460.
6. Bottone, E.J., Yersinia enterocolitica: the charisma continues. Clin. Microbiol. Rev. 10 (1997), 257–276.
7. Buonocore, S., Ahern, P.P., Uhlig, H.H., Ivanov, I.I., Littman, D.R., Maloy, K.J., Powrie, F., Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464 (2010), 1371–1375.
8. Cai, G., Freeman, G.J., The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol. Rev. 229 (2009), 244–258.
9. Cardoso, V., Chesne, J., Ribeiro, H., Garcia-Cassani, B., Carvalho, T., Bouchery, T., Shah, K., Barbosa-Morais, N.L., Harris, N., Veiga-Fernandes, H., Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. Nature 549 (2017), 277–281.
10. Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J.K., Doherty, J.M., Mills, J.C., Colonna, M., A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457 (2009), 722–725.
11. Chan, W., Costantino, N., Li, R., Lee, S.C., Su, Q., Melvin, D., Court, D.L., Liu, P., A recombineering based approach for high-throughput conditional knockout targeting vector construction. Nucleic Acids Res., 35, 2007, e64.
12. Cohavy, O., Zhou, J., Granger, S.W., Ware, C.F., Targan, S.R., LIGHT expression by mucosal T cells may regulate IFN-gamma expression in the intestine. J. Immunol. 173 (2004), 251–258.
13. Compaan, D.M., Gonzalez, L.C., Tom, I., Loyet, K.M., Eaton, D., Hymowitz, S.G., Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex. J. Biol. Chem. 280 (2005), 39553–39561.
14. Cover, T.L., Aber, R.C., Yersinia enterocolitica. N. Engl. J. Med. 321 (1989), 16–24.
15. DePaolo, R.W., Kamdar, K., Khakpour, S., Sugiura, Y., Wang, W., Jabri, B., A specific role for TLR1 in protective T(H)17 immunity during mucosal infection. J. Exp. Med. 209 (2012), 1437–1444.
16. Eberl, G., Littman, D.R., Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells. Science 305 (2004), 248–251.
17. Eberl, G., Marmon, S., Sunshine, M.J., Rennert, P.D., Choi, Y., Littman, D.R., An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5 (2004), 64–73.
18. Echeverry, A., Saijo, S., Schesser, K., Adkins, B., Yersinia enterocolitica promotes robust mucosal inflammatory T-cell immunity in murine neonates. Infect. Immun. 78 (2010), 3595–3608.
19. Fan, Z., Yu, P., Wang, Y., Wang, Y., Fu, M.L., Liu, W., Sun, Y., Fu, Y.X., NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors. Blood 107 (2006), 1342–1351.
20. Glaus, P., Honkela, A., Rattray, M., Identifying differentially expressed transcripts from RNA-seq data with biological variation. Bioinformatics 28 (2012), 1721–1728.
21. Goto, Y., Obata, T., Kunisawa, J., Sato, S., Ivanov, I.I., Lamichhane, A., Takeyama, N., Kamioka, M., Sakamoto, M., Matsuki, T., et al. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science, 345, 2014, 1254009.
22. Gronke, K., Kofoed-Nielsen, M., Diefenbach, A., Isolation and flow cytometry analysis of innate lymphoid cells from the intestinal lamina propria. Methods Mol. Biol. 1559 (2017), 255–265.
23. Guo, X., Muite, K., Wroblewska, J., Fu, Y.X., Purification and adoptive transfer of group 3 gut innate lymphoid cells. Methods Mol. Biol. 1422 (2016), 189–196.
24. Gury-BenAri, M., Thaiss, C.A., Serafini, N., Winter, D.R., Giladi, A., Lara-Astiaso, D., Levy, M., Salame, T.M., Weiner, A., David, E., et al. The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome. Cell. 166 (2016), 1231–1246.e13.
25. Herro, R., Shui, J.W., Zahner, S., Sidler, D., Kawakami, Y., Kawakami, T., Tamada, K., Kronenberg, M., Croft, M., LIGHT-HVEM signaling in keratinocytes controls development of dermatitis. J. Exp. Med. 215 (2018), 415–422.
26. Ibiza, S., Garcia-Cassani, B., Ribeiro, H., Carvalho, T., Almeida, L., Marques, R., Misic, A.M., Bartow-McKenney, C., Larson, D.M., Pavan, W.J., et al. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature 535 (2016), 440–443.
27. Kim, M.Y., Toellner, K.M., White, A., McConnell, F.M., Gaspal, F.M., Parnell, S.M., Jenkinson, E., Anderson, G., Lane, P.J., Neonatal and adult CD4+ CD3− cells share similar gene expression profile, and neonatal cells up-regulate OX40 ligand in response to TL1A (TNFSF15). J. Immunol. 177 (2006), 3074–3081.
28. Klose, C.S., Kiss, E.A., Schwierzeck, V., Ebert, K., Hoyler, T., d'Hargues, Y., Goppert, N., Croxford, A.L., Waisman, A., Tanriver, Y., et al. A T-bet gradient controls the fate and function of CCR6-RORgammat+ innate lymphoid cells. Nature 494 (2013), 261–265.
29. Klose, C.S.N., Mahlakoiv, T., Moeller, J.B., Rankin, L.C., Flamar, A.L., Kabata, H., Monticelli, L.A., Moriyama, S., Putzel, G.G., Rakhilin, N., et al. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. Nature 549 (2017), 282–286.
30. Luci, C., Reynders, A., Ivanov, I.I., Cognet, C., Chiche, L., Chasson, L., Hardwigsen, J., Anguiano, E., Banchereau, J., Chaussabel, D., et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10 (2009), 75–82.
31. Marsters, S.A., Ayres, T.M., Skubatch, M., Gray, C.L., Rothe, M., Ashkenazi, A., Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J. Biol. Chem. 272 (1997), 14029–14032.
32. Meylan, F., Hawley, E.T., Barron, L., Barlow, J.L., Penumetcha, P., Pelletier, M., Sciume, G., Richard, A.C., Hayes, E.T., Gomez-Rodriguez, J., et al. The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells. Mucosal Immunol. 7 (2014), 958–968.
33. Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., Cheroutre, H., Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 (2007), 256–260.
34. Murphy, T.L., Murphy, K.M., Slow down and survive: enigmatic immunoregulation by BTLA and HVEM. Annu. Rev. Immunol. 28 (2010), 389–411.
35. Narni-Mancinelli, E., Chaix, J., Fenis, A., Kerdiles, Y.M., Yessaad, N., Reynders, A., Gregoire, C., Luche, H., Ugolini, S., Tomasello, E., et al. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc. Natl. Acad. Sci. USA 108 (2011), 18324–18329.
36. Pearson, C., Thornton, E.E., McKenzie, B., Schaupp, A.L., Huskens, N., Griseri, T., West, N., Tung, S., Seddon, B.P., Uhlig, H.H., et al. ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation. Elife, 5, 2016, e10066.
37. Ramskold, D., Wang, E.T., Burge, C.B., Sandberg, R., An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput. Biol., 5, 2009, e1000598.
38. Sadighi Akha, A.A., McDermott, A.J., Theriot, C.M., Carlson, P.E. Jr., Frank, C.R., McDonald, R.A., Falkowski, N.R., Bergin, I.L., Young, V.B., Huffnagle, G.B., Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice. Immunology 144 (2015), 587–597.
39. Samten, B., Townsend, J.C., Weis, S.E., Bhoumik, A., Klucar, P., Shams, H., Barnes, P.F., CREB, ATF, and AP-1 transcription factors regulate IFN-gamma secretion by human T cells in response to mycobacterial antigen. J. Immunol. 181 (2008), 2056–2064.
40. Sanos, S.L., Bui, V.L., Mortha, A., Oberle, K., Heners, C., Johner, C., Diefenbach, A., RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 10 (2009), 83–91.
41. Satoh-Takayama, N., Vosshenrich, C.A., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J.J., Thiam, K., Cerf-Bensussan, N., Mandelboim, O., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29 (2008), 958–970.
42. Shui, J.W., Kronenberg, M., HVEM: an unusual TNF receptor family member important for mucosal innate immune responses to microbes. Gut Microbes 4 (2013), 146–151.
43. Shui, J.W., Larange, A., Kim, G., Vela, J.L., Zahner, S., Cheroutre, H., Kronenberg, M., HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria. Nature 488 (2012), 222–225.
44. Sica, A., Dorman, L., Viggiano, V., Cippitelli, M., Ghosh, P., Rice, N., Young, H.A., Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J. Biol. Chem. 272 (1997), 30412–30420.
45. Simoni, Y., Fehlings, M., Kloverpris, H.N., McGovern, N., Koo, S.L., Loh, C.Y., Lim, S., Kurioka, A., Fergusson, J.R., Tang, C.L., et al. Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency. Immunity 46 (2017), 148–161.
46. Song, C., Lee, J.S., Gilfillan, S., Robinette, M.L., Newberry, R.D., Stappenbeck, T.S., Mack, M., Cella, M., Colonna, M., Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation. J. Exp. Med. 212 (2015), 1869–1882.
47. Sonnenberg, G.F., Monticelli, L.A., Elloso, M.M., Fouser, L.A., Artis, D., CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34 (2011), 122–134.
48. Steinberg, M.W., Huang, Y., Wang-Zhu, Y., Ware, C.F., Cheroutre, H., Kronenberg, M., BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection. PLoS One, 8, 2013, e77992.
49. Steinberg, M.W., Turovskaya, O., Shaikh, R.B., Kim, G., McCole, D.F., Pfeffer, K., Murphy, K.M., Ware, C.F., Kronenberg, M., A crucial role for HVEM and BTLA in preventing intestinal inflammation. J. Exp. Med. 205 (2008), 1463–1476.
50. Tamada, K., Shimozaki, K., Chapoval, A.I., Zhai, Y., Su, J., Chen, S.F., Hsieh, S.L., Nagata, S., Ni, J., Chen, L., LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 164 (2000), 4105–4110.
51. Trulzsch, K., Oellerich, M.F., Heesemann, J., Invasion and dissemination of Yersinia enterocolitica in the mouse infection model. Adv. Exp. Med. Biol. 603 (2007), 279–285.
52. Trulzsch, K., Sporleder, T., Igwe, E.I., Russmann, H., Heesemann, J., Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infect. Immun. 72 (2004), 5227–5234.
53. Tu, T.C., Brown, N.K., Kim, T.J., Wroblewska, J., Yang, X., Guo, X., Lee, S.H., Kumar, V., Lee, K.M., Fu, Y.X., CD160 is essential for NK-mediated IFN-gamma production. J. Exp. Med. 212 (2015), 415–429.
54. Vonarbourg, C., Mortha, A., Bui, V.L., Hernandez, P.P., Kiss, E.A., Hoyler, T., Flach, M., Bengsch, B., Thimme, R., Holscher, C., et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 33 (2010), 736–751.
55. Walisser, J.A., Glover, E., Pande, K., Liss, A.L., Bradfield, C.A., Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proc. Natl. Acad. Sci. USA 102 (2005), 17858–17863.
56. Wallrapp, A., Riesenfeld, S.J., Burkett, P.R., Abdulnour, R.E., Nyman, J., Dionne, D., Hofree, M., Cuoco, M.S., Rodman, C., Farouq, D., et al. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature 549 (2017), 351–356.
57. Yu, X., Pappu, R., Ramirez-Carrozzi, V., Ota, N., Caplazi, P., Zhang, J., Yan, D., Xu, M., Lee, W.P., Grogan, J.L., TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol. 7 (2014), 730–740.
58. Zheng, Y., Valdez, P.A., Danilenko, D.M., Hu, Y., Sa, S.M., Gong, Q., Abbas, A.R., Modrusan, Z., Ghilardi, N., de Sauvage, F.J., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14 (2008), 282–289.